Hicin Pharmaceutical(SZ:300584) Xin Lang Cai Jing·2025-11-11 03:36Core Viewpoint - On November 11, Hainan Pharmaceutical experienced a 5.08% increase in stock price, reaching 57.13 CNY per share, with a trading volume of 204 million CNY and a turnover rate of 4.48%, resulting in a total market capitalization of 6.856 billion CNY [1] Company Overview - Nanjing Hainan Pharmaceutical Co., Ltd. was established on January 15, 2003, and listed on January 12, 2017. The company specializes in the research, production, and sales of chemical preparations, active pharmaceutical ingredients, and intermediates [1] - The revenue composition of the company's main business includes: cardiovascular drugs 87.12%, antibiotics 5.69%, active pharmaceutical ingredients and intermediates 1.68%, digestive drugs 1.50%, antiviral drugs 1.47%, and other categories [1] Shareholder Information - Yongying Fund has a fund that ranks among the top ten circulating shareholders of Hainan Pharmaceutical. The Yongying New Materials Smart Selection Mixed Fund A (024737) entered the top ten shareholders in the third quarter, holding 482,400 shares, which accounts for 0.59% of the circulating shares. The estimated floating profit today is approximately 1.3314 million CNY [2] - The Yongying New Materials Smart Selection Mixed Fund A (024737) was established on July 28, 2025, with a latest scale of 71.9734 million CNY and a return of 19.26% since inception [2] Fund Manager Profile - The fund manager of Yongying New Materials Smart Selection Mixed Fund A (024737) is Ou Zichen. As of the report, Ou has been in the position for 3 years and 278 days, managing total assets of 2.624 billion CNY. The best fund return during his tenure is 88.41%, while the worst return is -11.01% [3]